Next Financial Group’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3K Hold
851
﹤0.01% 2576
2021
Q3
$3K Hold
851
﹤0.01% 2433
2021
Q2
$4K Sell
851
-1,000
-54% -$4.07K ﹤0.01% 2291
2021
Q1
$8K Buy
1,851
+1,000
+118% +$4.33K ﹤0.01% 1980
2020
Q4
$3K Hold
851
﹤0.01% 2152
2020
Q3
$2K Buy
+851
New +$2.35K ﹤0.01% 2068
2020
Q2
Sell
-851
Closed -$2K 2058
2020
Q1
$2K Hold
851
﹤0.01% 1968
2019
Q4
$4K Hold
851
﹤0.01% 2051
2019
Q3
$3K Hold
851
﹤0.01% 2065
2019
Q2
$3K Buy
+851
New +$2.46K ﹤0.01% 2064

Other funds holding ATRS

Next Financial Group's ATRS Position: Q4 2021 in Review

Next Financial Group held its Antares Pharma, Inc. (ATRS) position steady in Q4 2021 at 851 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2576.

Next Financial Group first reported a position in ATRS in Q2 2019 and has held it in 10 quarters since. The position peaked at $8K in Q1 2021. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Next Financial Group held 851 shares of Antares Pharma, Inc. worth $3K as of Q4 2021.
  • Next Financial Group left its Antares Pharma, Inc. share count unchanged in Q4 2021.
  • Antares Pharma, Inc. made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2576 holding.
  • Next Financial Group first reported a position in Antares Pharma, Inc. in Q2 2019 and has held it in 10 quarters since.
  • Next Financial Group's Antares Pharma, Inc. position peaked at $8K in Q1 2021.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.